Ads
related to: targeted alpha therapy- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Dosing & Administration
Learn About Important Dosing
Considerations For This Rx.
- $0 Co-Pay Information
Patients With Private Insurance
Could Save On Their Prescription.
- Clinical Trial Data
Physicians, Find Results And
Study Design Information.
- Support & Financial Info
HCPs, Connect Your Patients With
Savings & Support Resources.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Treatment Option
Prescription-treatment-website.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. [1] It has the potential to provide highly targeted treatment, especially to microscopic tumour cells.
About Targeted Alpha Therapy Targeted alpha therapy (TAT) relies on a simple concept: combining the ability of biological molecules to target cancer cells with the short-range cell-killing capabilities of alpha-emitting radioisotopes. Alpha decay consists of the emission of a helium nucleus (alpha particle) together with very high linear energy ...
Biomarkers are usually required to aid the selection of patients who will likely respond to a given targeted therapy. [6] Co-targeted therapy involves the use of one or more therapeutics aimed at multiple targets, for example PI3K and MEK, in an attempt to generate a synergistic response [5] and prevent the development of drug resistance. [7] [8]
This is a type of targeted therapy which uses the physical, chemical and biological properties of the radiopharmaceutical to target areas of the body for radiation treatment. [3] The related diagnostic modality of nuclear medicine employs the same principles but uses different types or quantities of radiopharmaceuticals in order to image or ...
The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225 Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
[5] [6] Radium-223 dichloride is an alpha particle-emitting radiotherapy drug that mimics calcium and forms complexes with hydroxyapatite at areas of increased bone turnover. [7] The principal use of radium-223, as a radiopharmaceutical to treat metastatic cancers in bone , takes advantage of its chemical similarity to calcium , and the short ...
Ads
related to: targeted alpha therapyPrescription-treatment-website.com has been visited by 10K+ users in the past month